Loading clinical trials...
Loading clinical trials...
Financial Incentives for Smoking Treatment
Conditions
Interventions
Smoking cessation counseling (Quitline)
Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
+2 more
Locations
2
United States
David Geffen School of Medicine
Los Angeles, California, United States
NYU Langone Health
New York, New York, United States
Start Date
January 6, 2020
Primary Completion Date
December 31, 2024
Completion Date
June 30, 2025
Last Updated
May 2, 2024
NCT06598397
NCT07441928
NCT07080788
NCT05846841
NCT07210567
NCT05445804
Lead Sponsor
University of California, Los Angeles
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions